# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001790340-24-000046
Filing Date
2024-04-23
Accepted
2024-04-23 16:17:45
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | imrx-2024additionalproxyma.htm | DEFA14A | 11974
2 |  | additionalmaterialsjpg_pag.jpg | GRAPHIC | 497354
3 |  | additionalmaterialsjpg_paga.jpg | GRAPHIC | 315620
| Complete submission text file | 0001790340-24-000046.txt |  | 1132299

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40675 | Film No.: 24865052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)